New Delhi: India will explore novel blood plasma therapy for COVID-19 using the immune power gained by a recovered person to treat a sick person.
Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an Institution of National Importance under the Department of Science and Technology, has obtained the go-ahead for taking a bold step to provide innovative treatment to patients suffering from COVID-19 disease.
Technically called "convalescent-plasma therapy", the treatment aims at using the immune power gained by a recovered person to treat a sick person.
According to a statement by Ministry of Science & Technology, the Indian council for medical research (ICMR), the top authorising body in India, has given approval to the SCTIMST for carrying out the novel treatment.
"We have applied for age cutoff to the Drug Controller General of India (DCGI) for permissions for relaxation of the norms for blood donation," said Asha Kishore Director, SCTIMST.
The therapy, like blood transfusion, harvests the antibody from a recovered patient and ingest into a sick person. Helped by the antibody, the immune system mounts robust combat on the virus.
"Initially, we will try in a small number of patients. At present it is permitted as an experimental therapy for restricted use for severely affected patients only. We will be getting the informed consent before they are recruited. This will be conducted as a clinical trial," said Kishore.
"COVID clinics of five medical college hospitals will be partnering," he said.
In this procedure, blood is drawn from a person who has recovered from COVID-19 sickness. The serum is separated and screened for virus-neutralizing antibodies. Convalescent serum, that is the blood serum obtained from one who has recovered from an infectious disease and especially rich in antibodies for that pathogen, is then administered to a Coronavirus patient. The sick acquires passive immunization.
This therapy is not simple to harness, primarily due to the difficulty of obtaining significant amounts of plasma from survivors. In diseases like COVID-19, where most of the victims are aged, suffering from other medical conditions such as hypertension, diabetes, and so on, not all recovered patients can volunteer to donate blood.
For all the latest News, Opinions and Views, download ummid.com App.
Select Language To Read in Urdu, Hindi, Marathi or Arabic.
Malegaon Coronavirus: 4 new cases, 1 tests positive in Chandwad
Also Read
5 test positive for Coronavirus in Malegaon, 1 dead
Two from Malegaon test Coronavirus positive in UP's Bulandshahr
Ramadan 2020 likely to start in Saudi Arabia on April 23, a day later in India, Pakistan
Muslim wagers, vendors bear the brunt of Coronavirus-Tablighi Jamaat link
Apologise, Pay 1 cr in Damages: Tablighi Jamaat legal notice to Times Now
7-yr-old with no Tablighi Jamaat link among new Gujarat Coronavirus cases
India stares at 150th Coronavirus death, Positive cases get past 5000
14-month-old dies of Coronavirus in Gujarat, State death tally surges
At Delhi's Bhagirath Palace, its as if the lockdown has already ended
Don't give communal colour to Coronavirus: TN CM
Makkah, Madinah report 96 new cases; Saudi Corona deaths surge
City of the Prophet Madinah reports 02 Coronavirus deaths
Necessary to extend Coronavirus lockdown till June: KCR
India Coronavirus lockdown may not end on April 14
"It's horrible": Doctor fighting Corona describes grim conditions at NY hospitals
With 356 deaths, Holland is new Coronavirus epicenter in Europe
Close to 150,000 Americans infected by Coronavirus
Coronavirus Latest Alert: US could be new epicentre by April
USA Covid-19 count surges past China, Italy; New York worst affected
Govt, not Tablighi Markaz, to blame for Corona Pandemics deaths
Six die in Telangana after visiting Tablighi Markaz in Delhi Nizamuddin
Coronavirus: FIR against Maulana Saad Kandhalvi of Nizamuddin Tablighi Markaz